Non-Analgesic Effects of Opioids: Cardiovascular Effects of Opioids and their Receptor Systems

被引:1
作者
Headrick, John P. [1 ]
Pepe, Salvatore [2 ,3 ]
Peart, Jason N. [1 ]
机构
[1] Griffith Univ, Heart Fdn Res Ctr, Griffith Hlth Inst, Nathan, Qld 4217, Australia
[2] Univ Melbourne, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia
[3] Univ Melbourne, Dept Paediat, Parkville, Vic 3052, Australia
基金
英国医学研究理事会; 澳大利亚研究理事会;
关键词
Opioid peptide; opioid receptor; cardiovascular system; cytoprotection; INDUCED DELAYED CARDIOPROTECTION; ISCHEMIA-REPERFUSION INJURY; PROENKEPHALIN MESSENGER-RNA; TYROSINE KINASE INHIBITORS; CARDIAC ADRENERGIC CELLS; REDUCES INFARCT SIZE; CORONARY BLOOD-FLOW; K-ATP CHANNELS; CROSS-TALK; ENDOGENOUS OPIOIDS;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Opioid peptides and their G protein-coupled receptors (GPCRs) are important regulators within the cardiovascular system, implicated in modulation of electrophysiological function, heart rate, myocardial inotropy, vascular function, and cellular stress resistance. The opioid system is also involved in cardiovascular development, adaptation to injury and effects of advanced age. The significant roles of opioids are emphasized by the observation that the heart produces prodynorphin and proenkephalin, which are enzymatically processed from small to large active polypeptides. Indeed, depending on species, cardiac preproenkephalin mRNA levels are comparable to or higher than those found in the central nervous system. This review highlights and discusses current knowledge and recent findings regarding physiological and pathophysiological modulation of the heart and vessels by the opioid receptor system.
引用
收藏
页码:6090 / 6100
页数:11
相关论文
共 193 条
  • [1] Morphine is an arteriolar vasodilator in man
    Afshari, Reza
    Maxwell, Simon R. J.
    Webb, David J.
    Bateman, D. Nicholas
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 67 (04) : 386 - 393
  • [2] Andrews CM, 2009, CARDIOL J, V16, P210
  • [3] Vagotonic effects of enkephalin are not mediated by sympatholytic mechanisms
    Barlow, MA
    Deo, S
    Johnson, S
    Caffrey, JL
    [J]. EXPERIMENTAL BIOLOGY AND MEDICINE, 2006, 231 (04) : 387 - 395
  • [4] Cardiac opioids
    Barron, BA
    [J]. PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 2000, 224 (01): : 1 - 7
  • [5] METHIONINE-ENKEPHALIN-ARG-PHE IMMUNOREACTIVITY IN HEART-TISSUE
    BARRON, BA
    OAKFORD, LX
    GAUGL, JF
    CAFFREY, JL
    [J]. PEPTIDES, 1995, 16 (07) : 1221 - 1227
  • [6] SCREENING FOR OPIOIDS IN DOG HEART
    BARRON, BA
    GU, H
    GAUGL, JF
    CAFFREY, JL
    [J]. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1992, 24 (01) : 67 - 77
  • [7] κ-Opioid receptor stimulation induces arrhythmia in the isolated rat heart via the protein kinase C/Na+-H+ exchange pathway
    Bian, JS
    Pei, JM
    Cheung, CS
    Zhang, WM
    Wong, TM
    [J]. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2000, 32 (08) : 1415 - 1427
  • [8] Phospholipase C inhibitors attenuate arrhythmias induced by κ-receptor stimulation in the isolated rat heart
    Bian, JS
    Zhang, WM
    Xia, Q
    Wong, TM
    [J]. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1998, 30 (10) : 2103 - 2110
  • [9] Kappa and delta opioid receptor signaling is augmented in the failing heart
    Bolte, Craig
    Newman, Gilbert
    Schultz, Jo El J.
    [J]. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2009, 47 (04) : 493 - 503
  • [10] Hypertensive state, independent of hypertrophy, exhibits an attenuated decrease in systolic function on cardiac κ-opioid receptor stimulation
    Bolte, Craig
    Newman, Gilbert
    Schultz, Jo El J.
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2009, 296 (04): : H967 - H975